WEDNESDAY, Feb. 14, 2018 — Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy.
Prostate cancer is the second-most-common form of…Original Article
New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
